Marina Orlova

Chief Strategy Officer at Selecta Biosciences

Marina Orlova's work experience begins with their current role as the Chief Strategy Officer at Selecta Biosciences. In this position, they are responsible for driving strategic initiatives, focusing on indication selection, business development, and cross-functional project support. Marina joined Selecta Biosciences in May 2022, and their employment there is ongoing.

Prior to their current role, Marina worked at Boston Consulting Group (BCG) from 2015 to 2022. Marina started as a Consultant in August 2015 and worked their way up to Project Leader in December 2017. From September 2019 to June 2021, they held the position of Principal, and from July 2021 onwards, they served as a Partner at BCG.

In 2014, Marina had a summer role as a Consultant at The Boston Consulting Group.

Before joining BCG, they worked at Nestlé S.A. from 2009 to 2013. Marina started as a Sales Coordinator in March 2009, followed by a role as a Business Analyst from September 2009 to December 2010. Marina became a Project Leader at Nestlé S.A. in January 2011 and held the position until July 2013.

Marina Orlova completed their education at multiple institutions. From 2004 to 2008, they attended the State University of Management (SUM), where they obtained a Specialist degree in Organization Management. Later, from 2013 to 2015, Marina pursued a Master of Business Administration (M.B.A.) at Columbia Business School.

In addition to their formal education, Marina Orlova also obtained several certifications. In 2019, they achieved Certificates of Achievement for completing the HMX Fundamentals - Physiology and HMX Fundamentals - Pharmacology programs offered by Harvard Medical School. In 2020, Marina received a certification for completing the Leading with Finance course from Harvard Business School Online. In 2021, they earned certificates in Introduction to the Biology of Cancer from The Johns Hopkins University and HMX Fundamentals - Genetics from Harvard Medical School. Marina also obtained a verified certificate for the edX course on Prescription Drug Regulation, Cost, and Access: Current Controversies in Context.

Links

Timeline

  • Chief Strategy Officer

    May, 2022 - present

View in org chart